Cross Country Healthcare (CCRN) Director Bhamidipati Venkat Sells Shares

What Happened
Bhamidipati Venkat, a director of Cross Country Healthcare, disposed of 29,759 shares at $13.25 per share for total proceeds of $394,307 on July 21, 2026. The disposition was a cash-out to the issuer pursuant to the merger of Cross Country Healthcare into a wholly owned subsidiary of the buyer.

Key Details

• Transaction date and price: 2026-07-21, $13.25 per share; total $394,307.
• Transaction type: Disposition to issuer (D) — shares converted to cash under the Merger Agreement.
• Footnotes: F1/F2 state that at the Effective Time of the Merger each outstanding common share was converted into the right to receive $13.25 in cash; restricted stock awards were fully vested, cancelled and converted into cash equal to the number of underlying shares × $13.25.
• Shares owned after transaction: The filing indicates conversion/cancellation of shares under the merger; the Form 4 does not report retained common shares post-Effective Time.
• Filing timeliness: Form filed the same day (2026-07-21), indicating a timely report.

Context
This was not an open-market sale driven by trading choice but a merger cash-out under the Merger Agreement—common shares (and restricted awards) were converted into a fixed cash amount. Such transactions reflect the deal terms rather than an insider judgment about the stock’s near-term prospects.